F. Guerrero‐Romero

发表

Hypomagnesemia and prehypertension in otherwise healthy individuals.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2014, European journal of internal medicine.

Demographic history and biologically relevant genetic variation of Native Mexicans inferred from whole-genome sequencing

J. Fernández-López, L. Orozco, E. Morett, 2017, Nature Communications.

[Games as an alternative for teaching basic health concepts].

M. Rodríguez-Moran, F. Guerrero‐Romero, J. M. Castillo Lizardo, 2001, Revista panamericana de salud publica = Pan American journal of public health.

Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes.

M. Rodríguez-Moran, F. Guerrero‐Romero, 1998, Journal of diabetes and its complications.

The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2012, European journal of gastroenterology & hepatology.

Metabolic syndrome among children and adolescents aged 10-18 years.

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Violante, 2004, Diabetes care.

Nonalcoholic fatty liver disease in asymptomatic obese women.

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2010, Annals of hepatology.

Cost-effectiveness analysis of using oral magnesium supplementation in the treatment of prediabetes.

F. Guerrero‐Romero, A. Nevárez-Sida, 2022, Primary care diabetes.

The Triglycerides and Glucose Index is Negatively Associated with Insulin Secretion in Young Adults with Normal Weight.

F. Guerrero‐Romero, R. Gómez-Díaz, N. Wacher, 2022, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Fasting Triglycerides and Glucose Index as a Diagnostic Test for Insulin Resistance in Young Adults.

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Villalobos-Molina, 2016, Archives of medical research.

Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, Lázaro Barragan-Rodríguez, 2008, Magnesium research.

Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes.

M. Rodríguez-Moran, F. Guerrero‐Romero, G. Lazcano-Burcíaga, 1998, Journal of diabetes and its complications.

Placental immaturity and hyperinsulinaemia in full‐term newborns

M. Rodríguez-Moran, F. Guerrero‐Romero, B. Sánchez-Ramírez, 2007, European journal of clinical investigation.

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2003, Diabetes care.

Obesity and hypomagnesemia.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2016, European journal of internal medicine.

No positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: a pilot study.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2012, Magnesium research.

Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2009, Pediatric diabetes.

Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Violante, 2009, Paediatric and perinatal epidemiology.

Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

P. Lutsey, M. Rodríguez-Moran, F. Guerrero‐Romero, 2016, Advances in nutrition.

C-reactive protein is directly associated with urinary albumin-to-creatinine ratio.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2011, Archives of medical research.

Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase/alanine aminotransferase ratio in young adults with normal weight

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Gómez-Díaz, 2017, European journal of gastroenterology & hepatology.

A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control.

A. Sahebkar, M. Rodríguez-Moran, F. Guerrero‐Romero, 2016, Pharmacological research.

Magnesium Intake and the Incidence of Type 2 Diabetes

M. Rodríguez-Moran, F. Guerrero‐Romero, 2007 .

Increased levels of C-reactive protein in noncontrolled type II diabetic subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, 1999, Journal of diabetes and its complications.

Magnesium in Infectious Diseases in Older People

M. Barbagallo, N. Veronese, F. Guerrero‐Romero, 2021, Nutrients.

Magnesium-to-Calcium Ratio and Mortality from COVID-19

M. Rodríguez-Moran, F. Guerrero‐Romero, A. Ferreira-Hermosillo, 2022, Nutrients.

Serum uric acid concentrations are directly associated with the presence of benign multiple sclerosis

F. Guerrero‐Romero, L. E. Simental-Mendía, Esteban Simental-Mendía, 2017, Neurological Sciences.

Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2003, Archives of medical research.

Fasting plasma glucose diagnostic criterion, proposed by the American Diabetes Association, has low sensitivity for diagnoses of diabetes in Mexican population.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2001, Journal of diabetes and its complications.

BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.

M. Rodríguez-Moran, F. Guerrero‐Romero, M. Reyes-Romero, 2015, Genetics and molecular research : GMR.

Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet.

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2011, Annals of hepatology.

The fat-to-lean mass ratio, a novel anthropometric index, is associated to glucose metabolic disorders.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2019, European journal of internal medicine.

Depressive symptoms and hypomagnesemia in older diabetic subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, Lázaro Barragan-Rodríguez, 2007, Archives of medical research.

Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2005, Archives of medical research.

Magnesium intake is associated with the metabolically healthy obese phenotype

F. Guerrero‐Romero, L. E. Simental-Mendía, G. Morales-Gurrola, 2021, Journal of Investigative Medicine.

ORIGINAL ARTICLE Hyperinsulinemia and Abdominal Obesity Are More Prevalent in Non-Diabetic Subjects with Family History of Type 2 Diabetes

M. Rodríguez-Moran, F. Guerrero‐Romero, 2000 .

The ratio potassium‐to‐magnesium intake and high blood pressure

M. Rodríguez-Moran, F. Guerrero‐Romero, 2019, European journal of clinical investigation.

Low serum magnesium levels and metabolic syndrome

M. Rodríguez-Moran, F. Guerrero‐Romero, 2002, Acta Diabetologica.

Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2014, Archives of medical research.

The role of magnesium in type 2 diabetes: a brief based-clinical review.

M. Rodríguez-Moran, F. Guerrero‐Romero, Luis E Simental Mendía, 2011, Magnesium research.

Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects

M. Rodríguez-Moran, F. Guerrero‐Romero, 2002, International Journal of Obesity.

Klippel-Feil syndrome in a boy exposed inadvertently to cyclophosphamide during pregnancy: a case report.

F. Guerrero‐Romero, B. Lazalde, Jesús Grijalva-Flores, 2012, Birth defects research. Clinical and molecular teratology.

Inhibitory effect of Mexican oregano (Lippia graveolens Kunth) extracts on digestive enzymes in vitro, and beneficial impact on carbohydrates and lipids absorption in vivo.

F. Guerrero‐Romero, L. E. Simental-Mendía, M. González-Cortazar, 2022, Journal of ethnopharmacology.

Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2008, European journal of gastroenterology & hepatology.

Research update for articles published in EJCI in 2008

J. Martínez, J. Carrero, A. Kastrati, 2010 .

Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2000, Journal of diabetes and its complications.

Metabolically obese normal-weight children.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2012, World journal of clinical pediatrics.

Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease.

F. Guerrero‐Romero, L. E. Simental-Mendía, A. Sánchez‐García, 2021, Advances in experimental medicine and biology.

The Triglycerides and Glucose Index Is Associated with Mild Cognitive Impairment in Older Adults

F. Guerrero‐Romero, L. E. Simental-Mendía, C. Gamboa-Gómez, 2022, Endocrine research.

Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2005, Archives of medical research.

The relevance of magnesium homeostasis in COVID-19

M. Barbagallo, S. Castiglioni, F. Guerrero‐Romero, 2021, European Journal of Nutrition.

Placental SLC38A4 gene polymorphisms 1304 G > A and 292 C > T, and their association with glucose > 95 mg/dl in normal weight full-term healthy newborns.

M. Rodríguez-Moran, F. Guerrero‐Romero, M. Sosa-Macías, 2021, Boletin medico del Hospital Infantil de Mexico.

Alanine aminotransferase-to-triglycerides ratio: author's reply.

F. Guerrero‐Romero, 2013, European journal of gastroenterology & hepatology.

Lipoprotein(a) and Hyperinsulinemia in Healthy Normal-weight, Prepubertal Mexican Children

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Gamboa-Gómez, 2021, Endocrine research.

Family history of diabetes is associated with hypertriglyceridaemia in healthy normal‐weight children

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Gamboa-Gómez, 2020, Acta paediatrica.

Low birthweight and elevated levels of lipoprotein(a) in prepubertal children

M. Rodríguez-Moran, F. Guerrero‐Romero, 2014, Journal of paediatrics and child health.

The total body fat measured by bioelectrical impedance is associated with hyperinsulinaemia in apparently healthy adolescents

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2020, Acta paediatrica.

Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, Mario Salcedo-Alejos, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Reply: In regard to mechanisms involved in beneficial effects of magnesium supplementation.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2014, Archives of medical research.

Hypoglycemic and antioxidant effects of five commercial turmeric (Curcuma longa) supplements.

F. Guerrero‐Romero, L. E. Simental-Mendía, G. Martínez-Aguilar, 2020, Journal of food biochemistry.

The correct formula for the triglycerides and glucose index

F. Guerrero‐Romero, L. E. Simental-Mendía, L. Simental‐Mendía, 2020, European Journal of Pediatrics.

Development and validation of a tool for predicting type 2 diabetes in Mexican women of reproductive age.

Omar Yaxmehen Bello-Chavolla, C. Aguilar-Salinas, R. Rojas-Martínez, 2020, Endocrinologia, diabetes y nutricion.

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, F. Martínez-Martínez, 2006, Clinical nephrology.

Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2005, Clinical nephrology.

Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.

M. Rodríguez-Moran, F. Guerrero‐Romero, D. Amato, 1995, Clinical nephrology.

Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome

M. Rodríguez-Moran, F. Guerrero‐Romero, 2006, Diabetes/metabolism research and reviews.

Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2004, Magnesium research.

Pioglitazone increases serum magnesium levels in glucose-intolerant subjects. A randomized, controlled trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

A. Sahebkar, G. Watts, J. Golledge, 2016, Current pharmaceutical design.

Zinc deficiency is an independent risk factor for prehypertension in healthy subjects.

F. Guerrero‐Romero, L. E. Simental-Mendía, J. Burciaga-Nava, 2019, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats

F. Guerrero‐Romero, A. Sanz-Medel, M. Montes-Bayón, 2011, British Journal of Nutrition.

Hypoglycemic and antioxidant properties of konjac (Amorphophallus konjac) in vitro and in vivo.

F. Guerrero‐Romero, L. E. Simental-Mendía, C. Gamboa-Gómez, 2020, Journal of food biochemistry.

Hyperuricemia is Associated with the Presence of Metabolically Obese Normal-Weight and Metabolically Healthy Obese Phenotypes

F. Guerrero‐Romero, L. E. Simental-Mendía, L. Simental-Mendía, 2022, Endocrine research.

Prevalence of NIDDM in Indigenous Communities of Durango, Mexico

M. Rodríguez-Moran, F. Guerrero‐Romero, F. Sandoval-Herrera, 1996, Diabetes Care.

Clampless abdominal hysterectomy: a pilot study

M. Rodríguez-Moran, F. Guerrero‐Romero, Dagoberto Álvarez-Fernández, 2006, Gynecological Surgery.

Lower placental weight is associated with raised cord serum insulin concentrations at birth

M. Rodríguez-Moran, F. Guerrero‐Romero, M. Levario-Carrillo, 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

Aggravation by vanadium of magnesium deficiency in STZ-induced diabetic rats.

F. Guerrero‐Romero, A. Sanz-Medel, C. Lopez-Chaves, 2013, Magnesium research.

Magnesium improves the beta‐cell function to compensate variation of insulin sensitivity: double‐blind, randomized clinical trial

M. Rodríguez-Moran, F. Guerrero‐Romero, 2011, European journal of clinical investigation.

The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2008, Metabolic syndrome and related disorders.

Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

A. Sahebkar, M. Rodríguez-Moran, F. Guerrero‐Romero, 2017, Current pharmaceutical design.

Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials.

M. Rodríguez-Moran, F. Guerrero‐Romero, Francia O Jaquez-Chairez, 2016, Magnesium research.

Failure of beta‐cell function to compensate lack of insulin action in hyperuricemic subjects

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2009, Diabetes/metabolism research and reviews.

Family history of hypertension and cardiovascular risk factors in prepubertal children.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. E. Simental-Mendía, 2010, American journal of hypertension.

Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in children: a case-control study.

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Paniagua, 1995, The Journal of pediatrics.

Demographic history and biologically relevant genetic variation of Native Mexicans inferred from whole-genome sequencing

J. Fernández-López, L. Orozco, E. Morett, 2017, Nature Communications.

Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2015, Diabetes & metabolism.

Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Gamboa-Gómez, 2018, Advances in chronic kidney disease.

Serum magnesium and C-reactive protein levels

M. Rodríguez-Moran, F. Guerrero‐Romero, 2007, Archives of Disease in Childhood.

Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2001, Archives of medical research.

Severe hypomagnesemia and low-grade inflammation in metabolic syndrome.

M. Rodríguez-Moran, F. Guerrero‐Romero, Carmen Bermúdez-Peña, 2011, Magnesium research.

Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Tamez-Pérez, 2004, Diabetes & metabolism.

Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2014, Archives of medical research.

Hypomagnesemia and mortality in patients with type 2 diabetes.

M. Rodríguez-Moran, F. Guerrero‐Romero, J. A. Curiel-García, 2008, Magnesium research.

Low Serum Magnesium Levels and Its Association with High Blood Pressure in Children.

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Gómez-Díaz, 2016, The Journal of pediatrics.

No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia.

F. Guerrero‐Romero, J. Ble-Castillo, C. Tovilla-Zárate, 2014, Magnesium research.

The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial

M. Rodríguez-Moran, F. Guerrero‐Romero, 2009, Journal of Human Hypertension.

Insulin secretion is decreased in non‐diabetic individuals with hypomagnesaemia

M. Rodríguez-Moran, F. Guerrero‐Romero, 2011, Diabetes/metabolism research and reviews.

Hypomagnesaemia and risk for metabolic glucose disorders: a 10‐year follow‐up study

J. E. L. Peña, R. A. Rascón-Pacheco, M. Rodríguez-Moran, 2008, European journal of clinical investigation.

Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials

A. Sahebkar, M. Rodríguez-Moran, F. Guerrero‐Romero, 2017, European Journal of Clinical Pharmacology.

Recommendation on an updated standardization of serum magnesium reference ranges

M. Barbagallo, R. Touyz, F. Guerrero‐Romero, 2022, European Journal of Nutrition.

The triglyceride and glucose index is a useful biomarker to recognize glucose disorders in apparently healthy children and adolescents

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Gamboa-Gómez, 2020, European Journal of Pediatrics.

The hypertriglyceridemia is associated with isolated impaired glucose tolerance in subjects without insulin resistance

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2015, Endocrine research.

Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus

M. Rodríguez-Moran, F. Guerrero‐Romero, 2006, European journal of clinical investigation.

[Oral magnesium supplementation: an adjuvant alternative to facing the worldwide challenge of type 2 diabetes?].

M. Rodríguez-Moran, F. Guerrero‐Romero, 2014, Cirugia y cirujanos.

Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents.

R. A. Rascón-Pacheco, M. Rodríguez-Moran, F. Guerrero‐Romero, 2012, European journal of endocrinology.

Risk of microalbuminuria in relatives of subjects with diabetic nephropathy: a predictive model based on multivariable dimensionality reduction approach.

M. Rodríguez-Moran, F. Guerrero‐Romero, M. Reyes-Romero, 2015, Clinical nephrology.

SLC41A1 is the only magnesium responsive gene significantly overexpressed in placentas of preeclamptic women

M. Rodríguez-Moran, F. Guerrero‐Romero, J. Vormann, 2013, Hypertension in pregnancy.

Prevalence of Prehypertension in Mexico and Its Association With Hypomagnesemia.

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Revilla-Monsalve, 2015, American journal of hypertension.

Associated Risk Factors for Latent Tuberculosis Infection in Subjects with Diabetes.

M. Rodríguez-Moran, F. Guerrero‐Romero, J. Enciso-Moreno, 2015, Archives of medical research.

Oral magnesium supplementation decreases alanine aminotransferase levels in obese women.

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2010, Magnesium research.

Haptoglobin 2-2 Genotype Is Associated with TNF-α and IL-6 Levels in Subjects with Obesity

M. Rodríguez-Moran, F. Guerrero‐Romero, B. Lazalde, 2014, Disease markers.

The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2016, Annals of hepatology.

Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2003, Diabetes & metabolism.

The triglycerides and glucose index is associated with elevated blood pressure in apparently healthy children and adolescents

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Gómez-Díaz, 2019, European Journal of Pediatrics.

Adipocytokines and High Blood Pressure in Mexican Children

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Gómez-Díaz, 2019, Endocrine research.

The triglycerides and glucose index is associated with cardiovascular risk factors in normal-weight children and adolescents

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Gómez-Díaz, 2017, Pediatric Research.

Atherogenic indices and prehypertension in obese and non-obese children

M. Rodríguez-Moran, F. Guerrero‐Romero, J. M. Vargas Morales, 2013, Diabetes & vascular disease research.

Lowered criterion for normal fasting plasma glucose: impact on the detection of impaired glucose tolerance and metabolic syndrome.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2006, Archives of medical research.

The triglycerides and glucose index is associated with cardiovascular risk factors in metabolically obese normal-weight subjects

F. Guerrero‐Romero, J. Salas-Pacheco, F. Castellanos-Juárez, 2020, Journal of Endocrinological Investigation.

Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial.

F. Guerrero‐Romero, L. Simental-Mendía, L. Simental‐Mendía, 2019, Nutrition.

Hyperuricemia is associated with the increase of insulin release in non-obese subjects with normal glucose tolerance

M. Rodríguez-Moran, F. Guerrero‐Romero, Esteban Simental-Mendía, 2017, Endocrine research.

Relationship between elevated triglyceride levels with the increase of HOMA-IR and HOMA-β in healthy children and adolescents with normal weight

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Aradillas-García, 2015, European Journal of Pediatrics.

Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2013, European journal of internal medicine.

Cardiovascular risk factors and acculturation in Yaquis and Tepehuanos Indians from Mexico.

R. A. Rascón-Pacheco, M. Rodríguez-Moran, F. Guerrero‐Romero, 2008, Archives of medical research.

Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus.

M. Rodríguez-Moran, F. Guerrero‐Romero, 1999, Stroke.

Failure of beta-cell function for compensate variation in insulin sensitivity in hypomagnesemic subjects.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2009, Magnesium research.

Adding cognitive behavioural treatment to either low-carbohydrate or low-fat diets: differential short-term effects

M. Rodríguez-Moran, F. Guerrero‐Romero, H. Rodríguez-Hernández, 2009, British Journal of Nutrition.

Hyperinsulinemia in Healthy Children and Adolescents With a Positive Family History for Type 2 Diabetes

M. Rodríguez-Moran, F. Guerrero‐Romero, 2006, Pediatrics.

Prevalence of dyslipidemia in non-obese prepubertal children and its association with family history of diabetes, high blood pressure, and obesity.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2006, Archives of medical research.

Dietary factors related to the increase of cardiovascular risk factors in traditional Tepehuanos communities from Mexico. A 10 year follow-up study.

R. A. Rascón-Pacheco, M. Rodríguez-Moran, F. Guerrero‐Romero, 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

A simple thermal-detoxified method for castor bean (Ricinus communis L.) cake, and its potential nutraceutical properties

F. Guerrero‐Romero, R. Rosales-Serna, R. Jiménez-Ocampo, 2021, Industrial Crops and Products.

The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp.

M. Rodríguez-Moran, F. Guerrero‐Romero, E. Martínez-Abundis, 2010, The Journal of clinical endocrinology and metabolism.

The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity

F. Guerrero‐Romero, G. Martínez-Aguilar, L. Simental-Mendía, 2021, European Journal of Pediatrics.

The triglyceride and glucose index is useful for recognising insulin resistance in children

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2017, Acta paediatrica.

Birth-weight, insulin levels, and HOMA-IR in newborns at term

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2012, BMC Pediatrics.

Effect of Magnesium Supplementation on Lipid Profile: A Systematic Review of Randomized Clinical Trials

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Gamboa-Gómez, 2019, Bioactive Food as Dietary Interventions for Diabetes.

Impact of Nutritional Intervention on Length of Hospital Stay and Mortality among Hospitalized Patients with Malnutrition: A Clinical Randomized Controlled Trial

José M. Ramos-Delgado, F. Guerrero‐Romero, L. Morales-Garza, 2017, Journal of the American College of Nutrition.

Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta‐analysis of clinical trials

A. Sahebkar, G. Watts, J. Golledge, 2015, Diabetes, obesity & metabolism.

Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2005, Diabetes care.

Significance of magnesium in insulin resistance, metabolic syndrome, and diabetes – recommendations of the Association of Magnesium Research e.V

M. Barbagallo, M. Rodríguez-Moran, F. Guerrero‐Romero, 2017 .

Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study.

R. A. Rascón-Pacheco, M. Rodríguez-Moran, F. Guerrero‐Romero, 2008, Metabolic syndrome and related disorders.

Biochemical Characteristics and Risk Factors for Insulin Resistance at Different Levels of Obesity

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Aradillas-García, 2013, Pediatrics.

The ApoB/A-I ratio and metabolic syndrome in prepubertal children.

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Aradillas-García, 2013, Metabolic syndrome and related disorders.

Birth weight, family history of diabetes, and metabolic syndrome in children and adolescents.

M. Rodríguez-Moran, F. Guerrero‐Romero, Elizabeth Monreal‐Escalante, 2010, The Journal of pediatrics.

Insulin action and secretion in healthy Hispanic-Mexican first-degree relatives of subjects with Type 2 diabetes

M. Rodríguez-Moran, F. Guerrero‐Romero, E. Martínez-Abundis, 2001, Journal of endocrinological investigation.

Glucose intolerance is predicted by the high Fasting Insulin-to-Glucose ratio.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2001, Diabetes & metabolism.

The parental phenotype of diabetes, but not of essential hypertension, is linked to the development of metabolic syndrome in Mexican individuals

M. Rodríguez-Moran, F. Guerrero‐Romero, 2001, Acta Diabetologica.

Injection of absolute alcohol into cysts cavities, after cyst aspiration, for treating and reducing the rate of recurrence of benign breast cysts

M. Rodríguez-Moran, F. Guerrero‐Romero, J. González, 2010, Gynecological Surgery.

Relation Between C-Reactive Protein and Impaired Fasting Glucose in Obese Subjects

M. Rodríguez-Moran, F. Guerrero‐Romero, Graciela Zambrano-Galván, 2012, Inflammation.

Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity

F. Guerrero‐Romero, J. Salas-Pacheco, F. Castellanos-Juárez, 2023, Molecular Biology Reports.

Association of C-reactive protein levels with fasting and postload glucose levels according to glucose tolerance status.

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2014, Archives of medical research.

Association of the polymorphisms 292 C>T and 1304 G>A in the SLC38A4 gene with hyperglycaemia

M. Rodríguez-Moran, F. Guerrero‐Romero, I. Chairez-hernández, 2013, Diabetes/metabolism research and reviews.

Insulin resistance is independently related to age in Mexican women

M. Rodríguez-Moran, F. Guerrero‐Romero, 2003, Journal of endocrinological investigation.

Hypertriglyceridemia is associated with impaired fasting glucose in normal-weight children

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Aradillas-García, 2018, Pediatric Research.

Influence of coffee roasting degree on inflammatory and oxidative stress markers in high-fructose and saturated fat-fed rats.

F. Guerrero‐Romero, M. Anese, M. Alongi, 2023, Food research international.

Tumor necrosis factor haplotype diversity in Mestizo and native populations of Mexico.

M. Rodríguez-Moran, F. Guerrero‐Romero, S. Flores-Martínez, 2014, Tissue antigens.

[Validation of an instrument for screening cases of type 2 diabetes and monitoring at-risk individuals in Mexico].

M. Rodríguez-Moran, F. Guerrero‐Romero, 2010, Revista panamericana de salud publica = Pan American journal of public health.

The Fat-to-Lean Mass Ratio Is Associated with Hyperinsulinemia in Healthy Mexican Adolescents

M. Rodríguez-Moran, F. Guerrero‐Romero, C. Gamboa-Gómez, 2020, Journal of the American College of Nutrition.

Importance of Magnesium Status in COVID-19

M. Rodríguez-Moran, F. Guerrero‐Romero, Juergen Vormann, 2023, Biology.

Abbreviated title. HOMA-IR in children and adolescents

R. A. Rascón-Pacheco, M. Rodríguez-Moran, F. Guerrero‐Romero, 2011 .

Hypoglycemic and antioxidant effects of green tomato (Physalis ixocarpa Brot.) calyxes' extracts.

F. Guerrero‐Romero, C. Gamboa-Gómez, L. Simental-Mendía, 2021, Journal of food biochemistry.

Association of Interleukin-6 Haplotypes, Obesity, and Metabolic Abnormalities in a Population of Central Mexico

M. Rodríguez-Moran, F. Guerrero‐Romero, S. Flores-Martínez, 2010 .

Prevalence of hypertension in indigenous inhabitants of traditional communities from the north of Mexico

M. Rodríguez-Moran, F. Guerrero‐Romero, R. Alvarado-Ruiz, 2000, Journal of Human Hypertension.

Insulin secretion is increased in non‐diabetic subjects with fasting hypertriglyceridaemia

M. Rodríguez-Moran, F. Guerrero‐Romero, L. Simental-Mendía, 2013, Diabetes/metabolism research and reviews.

Early decrease of the percent of HOMA beta-cell function is independently related to family history of diabetes in healthy young nonobese individuals.

M. Rodríguez-Moran, F. Guerrero‐Romero, E. Martínez-Abundis, 2005, Diabetes & metabolism.

The effect of insulin resistance on breast cancer risk in Latinas of Mexican origin.

F. Guerrero‐Romero, A. M. Salinas-Martínez, J. Vázquez-Lara, 2014, Metabolic Syndrome and Related Disorders.

Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients

M. Rodríguez-Moran, F. Guerrero‐Romero, P. Cabrales, 2008, Vascular health and risk management.

Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2001, Journal of diabetes and its complications.

F. Guerrero‐Romero, L. Marchat, M. Sosa-Macías, 2018, Drug metabolism and personalized therapy.

Magnesium and the metabolic syndrome

M. Rodríguez-Moran, F. Guerrero‐Romero, 2019, Magnesium.

Elevated concentrations of C-reactive protein in subjects with Type 2 diabetes mellitus are moderately influenced by glycemic control

M. Rodríguez-Moran, F. Guerrero‐Romero, 2003, Journal of endocrinological investigation.

Severe hypomagnesemia and low-grade inflammation in metabolic syndrome.

M. Rodríguez-Moran, F. Guerrero‐Romero, Carmen Bermúdez-Peña, 2011, Magnesium research.

Low prevalence of non-insulin-dependent diabetes mellitus in indigenous communities of Durango, Mexico.

M. Rodríguez-Moran, F. Guerrero‐Romero, F. Sandoval-Herrera, 1997, Archives of medical research.

Association of the triglycerides and glucose index and the homeostatic model assessment of insulin resistance with lipoprotein(a), apolipoprotein AI, and apolipoprotein B concentrations in children with normal-weight

F. Guerrero‐Romero, A. Sánchez‐García, L. Simental‐Mendía, 2023, European Journal of Pediatrics.

Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents.

R. A. Rascón-Pacheco, M. Rodríguez-Moran, F. Guerrero‐Romero, 2012, European journal of endocrinology.

Effect of oral magnesium supplementation on the transcription of TRPM6, TRPM7, and SLC41A1 in individuals newly diagnosed of pre-hypertension. A randomized, double-blind, placebo-controlled trial.

M. Rodríguez-Moran, F. Guerrero‐Romero, M. Reyes-Romero, 2017, Magnesium research.

Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: a 15-year follow-up study.

M. Rodríguez-Moran, F. Guerrero‐Romero, 2014, European journal of internal medicine.

No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia.

F. Guerrero‐Romero, J. Ble-Castillo, C. Tovilla-Zárate, 2014, Magnesium research.

Relation Between C-Reactive Protein and Impaired Fasting Glucose in Obese Subjects

M. Rodríguez-Moran, F. Guerrero‐Romero, Graciela Zambrano-Galván, 2012, Inflammation.

Turmeric Plus Black Pepper for the Improvement and Remission of Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

F. Guerrero‐Romero, C. Gamboa-Gómez, Lucia Preza-Rodríguez, 2024, Journal of Herbal Medicine.